ESR1 and triple-negative breast carcinoma: MDA-MB-231 is representative of the highly aggressive triple-negative breast cancer (TNBC), and MCF7A represents the adherent derivation of a relatively less aggressive luminal type A cancer with estrogen receptor (ER)-positive and progesterone receptor (PR)-positive characteristics [31].